Tag: Biotech and Pharmaceuticals

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

White House to launch direct-to-consumer drug site Trump Rx. Here’s what to know

Eli Lilly’s GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026

Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

Merck tops quarterly estimates, posts modest 2026 guidance as generic competition looms

Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook

Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch

Eli Lilly plans $3.5 billion manufacturing plant in Pennsylvania to make next-generation obesity injections

Healthy Returns: Botox, Trulicity among 15 drugs added to Medicare price negotiations